Conference Reports

Apabetalone Reduces Risk of Major Cardiovascular Events After Recent ACS in Patients With Diabetes, Kidney Disease
By Chris Berrie CEPAGATTI, Italy -- June 16, 2020 -- Apabetalone reduces the risk of major adverse cardiovascular events (MACE) by 50% versus placebo in patients with type 2 diabetes, recent acute coronary syndrome (ACS), and chronic kidney disease (CKD), according to a study presented at the 2020...
Portable MRI Scanners Can Be Used at Bedside to Evaluate Stroke
By Alex Morrisson WEST PALM BEACH, Fla -- May 4, 2020 -- A low-field MRI scanner is feasible for use at the bedside of patients exhibiting symptoms of stroke, according to a study presented at the 2020 Virtual Meeting of the American Academy of Neurology (AAN). Kevin Sheth, MD, Yale School of...
Cilostazol Helps Prevent Carotid In-Stent Restenosis
By Alex Morrisson LOS ANGELES -- February 25, 2020 -- Patients undergoing carotid artery stenting to prevent recurrence of stroke who receive cilostazol tend to have a lower incidence of in-stent restenosis after 2 years, according to a study presented here at the 2020 International Stroke...
Lowering Bad Cholesterol to 70 mg/dL Reduces Risk of Ischaemic Stroke
By Alex Morrisson LOS ANGELES -- February 24, 2020 -- In patients with a history of stroke or transient ischaemic attacks, reducing low density lipoprotein (LDL) cholesterol to a goal of 70 mg/dL significantly reduces the risk of subsequent cardiovascular events, according to a study presented...
Treatment With Tranexamic Acid Shows Limited Effectiveness in Stopping Brain Bleeds
By Alex Morrisson LOS ANGELES -- February 24, 2020 -- Patients with stroke who are identified as having intracerebral haemorrhage (ICH) may be helped by treatment with tranexamic acid, according to a study presented here at the 2020 International Stroke Conference (ISC). While there were...
Year-Long Study Shows Brain Stenting Has Long-Term Effectiveness
By Alex Morrisson LOS ANGELES -- February 24, 2020 -- A long-term follow-up study appears to indicate that the Wingspan brain stent -- aimed at preventing recurrent strokes -- is safe and effective when used on-label, according to a study presented here at the 2020 International Stroke Conference...
Increasing Tenecteplase Dose Does Not Improve Reperfusion in Ischaemic Stroke
By Alex Morrisson LOS ANGELES -- February 24, 2020 -- Increasing the dose of tenecteplase prior to endovascular thrombectomy does not improve reperfusion or clinical outcomes in patients with stroke, according to a study presented here at the 2020 International Stroke Conference (ISC). In the...
Non-Invasive Device Stimulates Areas of Brain After Stroke, May Improve Motor Function
By Alex Morrisson LOS ANGELES -- February 24, 2020 -- A non-invasive device that looks like a swimmer’s cap appears to be able to stimulate areas of the brain in patients who have had a stroke, which may translate to improved motor function, according to a study presented here at the 2020...
Nerinetide Fails to Improve Stroke Outcomes After Endovascular Thrombectomy
By Alex Morrisson LOS ANGELES -- February 24, 2020 -- A novel purported neuroprotective agent, nerinetide, was unable to improve stroke outcomes after endovascular thrombectomy, according to a study presented here at the 2020 International Stroke Conference (ISC) and published simultaneously in...
Cerebral Blood Flow Velocity Predicts Outcomes Following Subarachnoid Haemorrhage
By Nancy Melville ORLANDO, Fla -- February 17, 2020 -- Elevations in cerebral blood flow velocity in the middle cerebral artery (MCA), as assessed with transcranial Doppler ultrasound, are associated with poor outcomes following subarachnoid haemorrhage, according to a study presented here at the...

Pages